Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMCIL LIMITED Net Asset Value 2025

Jun 2, 2025

64375_rns_2025-06-02_7ddcd475-c3cb-44d6-afe8-c7d3e8808213.pdf

Net Asset Value

Open in viewer

Opens in your device viewer

3 June 2025

==> picture [596 x 78] intentionally omitted <==

Monthly net tangible asset (NTA) backing per share and top 20 investments as at 31 May 2025


and top 20 investments as at 31 May 2025
Before Tax
After Tax
31 May2025 $1.28
$1.14
30 April 2025 $1.21
$1.09
  • The before and after tax numbers relate to the provision for deferred tax on the unrealised gains in the Company’s investment portfolio. The Company is a long-term investor and does not intend disposing of its total long term investment portfolio. Under current Accounting Standards, the Company is required to provide for tax on any gains that may arise on such a theoretical disposal, after the utilisation of any brought forward losses.

Key facts

Investment objectives: AMCIL is a medium to long-term investor in the Australian equity market. Its investment approach is to construct a focused portfolio in which large and small companies can have an equally important impact on investment returns.

Benchmark: S&P/ASX 200 Accumulation Index.

Size of portfolio: $405.9 million at 31 May 2025.

Low Management cost: 0.56 per cent, no additional fees.

Investment style: Active, fundamental, bottom-up.

Suggested investment period: Five years to 10 years or longer.

Key benefits

Diversified portfolio primarily of ASX-listed Australian equities.

Tax-effective income via fully franked dividends.

Consistent after tax paid investment returns achieved over the long term.

Professional management and an experienced Board, investment and management team.

Low-cost investing.

Ease of investing , transparent ASX pricing.

Shareholder meetings on a regular basis.

Net asset backing: Estimated NTA released weekly and a monthly NTA with top 20 investments.

Listed on ASX: code AMH.

Portfolio performance percentage per annum-periods ending 31 May 2025*

==> picture [241 x 148] intentionally omitted <==

----- Start of picture text -----

1 year return 3 year return 5 year return 10 year return
Net asset per share growth [S&P/ASX 200 Accumulation ]
plus dividends, including franking Index, including franking
14.6%
13.6%
11.1% 11.0%
10.6%
9.6%
9.1%
7.0%
----- End of picture text -----

  • Assumes an investor can take full advantage of the franking credits. AMCIL’s portfolio return is also calculated after management fees, income tax and capital gains tax on realised sales of investments. It should be noted that Index returns for the market do not include management expenses or tax.

Share price premium/discount to NTA

==> picture [17 x 198] intentionally omitted <==

----- Start of picture text -----

15%
10%
5%
0%
-5%
-10%
-15%
-20%
----- End of picture text -----

==> picture [210 x 124] intentionally omitted <==

Past performance is not indicative of future performance.

Release authorised by Matthew Rowe, Company Secretary AMCIL Limited (AMCIL) – ABN 57 073 990 735

Share Registrar

Level 21, 101 Collins Street, Melbourne Victoria 3000 (03) 9650 9911 | [email protected] | amcil.com.au

MUFG Corporate Markets (AU) Limited au.investorcentre.mpms.mufg.com

1300 847 879 (in Australia) [email protected]

Page 1 of 2

==> picture [595 x 100] intentionally omitted <==

Portfolio facts

Top 20 investments valued at closing prices at 30 May 2025

Total Value % of the
$ Million Portfolio
1 CSL 30.0 7.6%
2 Macquarie Group 22.0 5.6%
3 Wesfarmers* 18.6 4.7%
4 Goodman Group 18.0 4.5%
5 Transurban Group* 17.3 4.4%
6 BHP 16.9 4.3%
7 Mainfreight 16.2 4.1%
8 CAR Group 14.1 3.6%
9 ResMed 12.8 3.2%
10 Macquarie Technology Group 12.0 3.0%
11 ARB Corporation 11.9 3.0%
12 Netwealth Group 11.0 2.8%
13 WiseTech Global 10.6 2.7%
14 ALS 8.8 2.2%
15 James Hardie Industries 8.7 2.2%
16 EQT Holdings 8.7 2.2%
17 REA Group 8.5 2.1%
18 Gentrack Group 8.1 2.1%
19 Fisher & Paykel Healthcare Corporation 7.8 2.0%
20 Region Group 7.7 1.9%
Total 269.8
As percentage of total portfolio value (excludes cash) 68.3%

Investment by sector at 31 May 2025

==> picture [115 x 115] intentionally omitted <==

[Healthcare] [16.0%]

[Information Technology] [14.8%]

[Industrials ] [14.2%]

[Other Financials] [12.5%]

[Consumer Discretionary ] [10.5%]

[Communication Services ] [9.0%]

[Materials ] [8.2%]

[Real Estate ] [6.3%]

[Banks ] [2.9%]

[Cash] [2.6%]

[Consumer Staples] [1.8%]

[Energy ] [1.2%]

  • Indicates that options were outstanding against part of the holding.

Important Information

This information has been prepared by AMCIL Limited (AMCIL) (ABN 57 073 990 735) and is provided by Australian Investment Company Services Limited, holder of Australian Financial Services Licence 303209 (Provider). To the extent that this information includes any financial product advice, the advice is of a general nature only and does not take into account any individual’s objectives, financial situation or particular needs. Before making an investment decision an individual should assess whether it meets their own needs and consult an appropriately licensed financial adviser. The information contained in these materials have been prepared in good faith. However, no warranty (express or implied) is made as to the accuracy, completeness or reliability of any statements, estimates or opinions or other information contained in these materials (any of which may change without notice) and to the maximum extent permitted by law, the Disclosers disclaim all liability and responsibility (including, without limitation, any liability arising from fault or negligence on the part of any or all of the Disclosers) for any direct or indirect loss or damage which may be suffered by any recipient through relying on anything contained in or omitted from these materials. A copy of the relevant Financial Services Guide can be found on AMCIL’s website: www.amcil.com.au

Page 2 of 2